The new findings offer a step toward solving what has been one of the central problems of modern vaccine design.
The findings, from the Lasmézas lab, involve drugs already approved for human use.
A graduate chemistry class taught by Professor Phil Baran will focus on the versatile new resource, The Portable Chemist’s Consultant.